Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi
2023 · Molecular Therapy — Nucleic Acids · 8 citations
https://doi.org/10.1016/j.omtn.2023.102066
F
Fatma Zehra Hapil
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
237
Citations
6
h-index
4
i10-index
Fatma Zehra Hapil is an academic researcher from Akdeniz University. The author has contributed to research in topics: Cancer-related Molecular Pathways & Metabolism, Diabetes, and Cancer & Growth Hormone and Insulin-like Growth Factors. The author has an h-index of 6, co-authored 11 publications.
ORCID: 0000-0002-0055-9926Papers by this author
worksIdentification of novel mutations of Insulin Receptor Substrate 1 (IRS1) in tumor samples of non-small cell lung cancer (NSCLC): Implications for aberrant insulin signaling in development of cancer
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7773956
Identification of novel mutations of Insulin Receptor Substrate 1 (IRS1) in tumor samples of non-small cell lung cancer (NSCLC): Implications for aberrant insulin signaling in development of cancer
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7866035
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat